MarketScreener Editorial Features Bioheart, Inc. Other OTC
Equities
US09062F2011
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2023 | U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt | CI |
- Stock Market
- Equities
- USRM Stock
- Stock
- News Bioheart, Inc.
- MarketScreener Editorial Features